Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Apr;33(4):873-81.
doi: 10.1002/jmri.22514.

T(1) independent, T(2) (*) corrected chemical shift based fat-water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis

Affiliations

T(1) independent, T(2) (*) corrected chemical shift based fat-water separation with multi-peak fat spectral modeling is an accurate and precise measure of hepatic steatosis

Catherine D G Hines et al. J Magn Reson Imaging. 2011 Apr.

Abstract

Purpose: To determine the precision and accuracy of hepatic fat-fraction measured with a chemical shift-based MRI fat-water separation method, using single-voxel MR spectroscopy (MRS) as a reference standard.

Materials and methods: In 42 patients, two repeated measurements were made using a T(1) -independent, T 2*-corrected chemical shift-based fat-water separation method with multi-peak spectral modeling of fat, and T(2) -corrected single voxel MR spectroscopy. Precision was assessed through calculation of Bland-Altman plots and concordance correlation intervals. Accuracy was assessed through linear regression between MRI and MRS. Sensitivity and specificity of MRI fat-fractions for diagnosis of steatosis using MRS as a reference standard were also calculated.

Results: Statistical analysis demonstrated excellent precision of MRI and MRS fat-fractions, indicated by 95% confidence intervals (units of absolute percent) of [-2.66%,2.64%] for single MRI ROI measurements, [-0.81%,0.80%] for averaged MRI ROI, and [-2.70%,2.87%] for single-voxel MRS. Linear regression between MRI and MRS indicated that the MRI method is highly accurate. Sensitivity and specificity for detection of steatosis using averaged MRI ROI were 100% and 94%, respectively. The relationship between hepatic fat-fraction and body mass index was examined.

Conclusion: Fat-fraction measured with T(1) -independent T 2*-corrected MRI and multi-peak spectral modeling of fat is a highly precise and accurate method of quantifying hepatic steatosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Representative patient fat-fraction images and MRS spectra at Time 1 and Time 2. Patient 1, Patient 2, and Patient 3 are examples of severely elevated fat-fraction, mildly elevated fat-fraction, and a normal fat-fraction, respectively. The MRI fat-fraction recorded at the location of the MRS voxel is displayed on each fat-fraction image. MRS fat-fractions are as indicated on the spectra. Excellent agreement is seen between time points for individual readers, between different readers, and between techniques.
Figure 2
Figure 2
Bland-Altman plot between Time 1 and Time 2 for the MRI fat-fractions measured in each of the Couinaud segments for all volunteers, indicating high precision. The limits of agreement for Reader 1 (circles) are [−2.54%, 2.44%], denoted as a heavy dashed line. The limits of agreement for Reader 2 (squares) are [−2.76%, 2.83%], denoted as a fine dashed line. If data from both readers is pooled, the limits of agreement are [−2.66%, 2.64%].
Figure 3
Figure 3
Bland-Altman plot between Time 1 and Time 2 for average MRI fat-fraction across the liver. The limits of agreement for Reader 1 (circles), denoted as a heavy dashed line, are [−0.66%, 0.64%] and for Reader 2 (squares), denoted as a fine dashed line, are [−0.94%, 0.93%]. If data from both readers is pooled, the limits of agreement are [−0.81%, 0.80%].
Figure 4
Figure 4
Bland-Altman plot between Time 1 and Time 2 for MRS fat-fraction. The limits of agreement are [−2.70%, 2.87%].
Figure 5
Figure 5
Bland-Altman plot between Time 1 and Time 2 for R2 measurements. The limits of agreement for Reader 1 (circles), denoted as a heavy dashed line, are [−15.19 s−1, 13.84 s−1], and for Reader 2 (squares), denoted as a fine dashed line, are [−19.67 s−1, 18.42 s−1]. If data from both readers is pooled, the limits of agreement are [−17.39 s−1, 16.23 s−1].
Figure 6
Figure 6
Standard deviation over the liver versus average fat-fraction over the liver for Reader 1 at Time 1 and Time 2. Both axes are expressed in fat-fraction percent (%). A lower variance is seen in most patients that have low fat-fractions. In general, however, the variance of measurements was relatively independent as the variance plateaus at approximately 5% for a wide range of fat-fractions.
Figure 7
Figure 7
Linear regression of MRI fat-fraction measured in the location of the MRS voxel and MRS fat-fraction indicates high accuracy. Estimated slope, intercept, and r2 value are 1.04 ± 0.02, 0.06 ± 0.21, and 0.96, respectively. The slope and intercept are not significantly different from 1.0 and 0.0, respectively. An inset zoom of the 0–10% region is shown in the lower right hand corner. Heavy dashed line is unity, and 95% confidence interval of the slope is as fine dashed lines.
Figure 8
Figure 8
a: Regression of average MRI fat-fraction and BMI displays an exponential relationship for pooled readers. Line of best fit is y = 0.165e0.1089x and r2 is 0.55. b: Comparison of average MRI fat-fraction versus patients with a BMI above and below 25 kg/m2. All patients with a BMI below 25 kg/m2 have fat-fractions that are considered normal or healthy, although a wider range of fat-fractions is seen in patients with a BMI above 25 kg/m2.

Similar articles

Cited by

References

    1. Sass DA, Chang P, Chopra KB. Nonalcoholic fatty liver disease: a clinical review. Dig Dis Sci. 2005;50:171–180. - PubMed
    1. Harrison SA, Neuschwander-Tetri BA. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Clin Liver Dis. 2004;8:861–879. ix. - PubMed
    1. Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 2001;50:1844–1850. - PubMed
    1. Marchesini G, Brizi M, Morselli-Labate AM, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med. 1999;107:450–455. - PubMed
    1. Brunt EM. Nonalcoholic steatohepatitis. Semin Liver Dis. 2004;24:3–20. - PubMed

Publication types